Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men - PubMed (original) (raw)
Randomized Controlled Trial
Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men
Satoshi Fukumitsu et al. Nutr Res. 2010 Jul.
Abstract
The effects of flaxseed lignan (secoisolariciresinol diglucoside [SDG]) intake on hypercholesterolemia and liver disease risk factors in moderately hypercholesterolemic men were investigated. In a previous study, we reported that SDG attenuates high-fat, diet-induced hypercholesterolemia in mice. Here, we report a double-blinded, randomized, and placebo-controlled study in moderately hypercholesterolemic men in which we investigated the hypothesis that oral administration of SDG (20 or 100 mg) would decrease the level of blood cholesterol and liver disease risk factors induced by hypercholesterolemia in humans. Thirty men with total cholesterol levels of 4.65 to 6.21 mmol/L (180-240 mg/dL) were randomly assigned to 3 groups; 2 groups received flaxseed lignan capsules (SDG, 20 or 100 mg/d) and the other received placebo capsules for 12 weeks. We found that, compared to the subjects who received placebo, those who received 100 mg of SDG exhibited a significant reduction in the ratio of low-density lipoprotein/high-density lipoprotein cholesterol at baseline (P < .05) and at week 12 (P < .05). In addition, in SDG-treated subjects, we also observed a significant percentage decrease in the levels of glutamic pyruvic transaminase and gamma-glutamyl transpeptidase relative to the levels at baseline (P < .01) and a significant percentage decrease in the level of gamma-glutamyl transpeptidase relative to the placebo-treated group (P < .05). These results suggest that daily administration of 100 mg SDG can be effective at reducing blood level of cholesterol and hepatic diseases risk in moderately hypercholesterolemic men.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
- Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, Sun SZ. Zhang W, et al. Br J Nutr. 2008 Jun;99(6):1301-9. doi: 10.1017/S0007114507871649. Epub 2007 Dec 6. Br J Nutr. 2008. PMID: 18053310 Clinical Trial. - Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed.
Prasad K. Prasad K. Atherosclerosis. 2005 Apr;179(2):269-75. doi: 10.1016/j.atherosclerosis.2004.11.012. Epub 2005 Jan 26. Atherosclerosis. 2005. PMID: 15777541 - Flaxseed and cardiovascular health.
Prasad K. Prasad K. J Cardiovasc Pharmacol. 2009 Nov;54(5):369-77. doi: 10.1097/FJC.0b013e3181af04e5. J Cardiovasc Pharmacol. 2009. PMID: 19568181 Review. - Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial.
Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J. Maron DJ, et al. Arch Intern Med. 2003 Jun 23;163(12):1448-53. doi: 10.1001/archinte.163.12.1448. Arch Intern Med. 2003. PMID: 12824094 Clinical Trial. - Health effects with consumption of the flax lignan secoisolariciresinol diglucoside.
Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU, Alcorn J. Adolphe JL, et al. Br J Nutr. 2010 Apr;103(7):929-38. doi: 10.1017/S0007114509992753. Epub 2009 Dec 15. Br J Nutr. 2010. PMID: 20003621 Review.
Cited by
- Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review.
Mahdavi A, Bagherniya M, Mirenayat MS, Atkin SL, Sahebkar A. Mahdavi A, et al. Adv Exp Med Biol. 2021;1308:161-183. doi: 10.1007/978-3-030-64872-5_13. Adv Exp Med Biol. 2021. PMID: 33861444 Review. - Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions.
Laka K, Makgoo L, Mbita Z. Laka K, et al. Front Genet. 2022 Mar 22;13:841639. doi: 10.3389/fgene.2022.841639. eCollection 2022. Front Genet. 2022. PMID: 35391801 Free PMC article. Review. - Chronic marijuana use moderates the correlations of serum cholesterol with systemic mitochondrial function and fluid cognition.
Panee J, Pomozi V, Franke AA, Le Saux O, Gerschenson M. Panee J, et al. Mitochondrion. 2020 May;52:135-143. doi: 10.1016/j.mito.2020.03.006. Epub 2020 Mar 10. Mitochondrion. 2020. PMID: 32169611 Free PMC article. - Unveiling the potential of linseed mucilage, its health benefits, and applications in food packaging.
Chand M, Chopra R, Talwar B, Homroy S, Singh PK, Dhiman A, Payyunni AW. Chand M, et al. Front Nutr. 2024 Feb 7;11:1334247. doi: 10.3389/fnut.2024.1334247. eCollection 2024. Front Nutr. 2024. PMID: 38385008 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical